Effects of exercise and coenzyme Q10 supplementation on muscular functionality in elderly

Effects of resistance exercise and coenzyme Q10 supplementation on muscle mass, muscle strength and functionality in adult community-dwelling elderly Mexicans

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN15034140

Enrollment

100

Registered

2017-10-20

Start date

2014-11-01

Completion date

Unknown

Last updated

2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dynapenia, presarcopenia, sarcopenia Not Applicable Dynapenia, presarcopenia, sarcopenia

Interventions

All participants provide written informed consent before inclusion in the study. Participants are randomly allocated to one of four groups: Group 1: Participants receive resistance exercise and receiv

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adults between 60-74 years 2. Chronic degenerative diseases controlled 3. Provision of informed consent

Exclusion criteria

Exclusion criteria: 1. Participation in any physical training program. 2. Chronic illness which contributed to loss of muscle mass (arthritis, cancer, renal failure, HIV) 3. Cardiac conditions that made patients unable to perform exercise

Design outcomes

Primary

Measure	Time frame
1. Muscle strength is measured using the HGS using Jamar hand-held dynamometer (Lafayette) Maximum value of three repetitions with the dominant hand was recorded, with 1 minute between measurements to avoid fatigue at baseline and three months 2. Muscle mass is measured by bioelectrical impedance using four-pole mono-frequency equipment (50-kHz, Quantum X, RJL System)at baseline and three months 3. Functionality is evaluated by gait speed (400-m walk test) at baseline and three months	—

Measure

Time frame

1. Muscle strength is measured using the HGS using Jamar hand-held dynamometer (Lafayette) Maximum value of three repetitions with the dominant hand was recorded, with 1 minute between measurements to avoid fatigue at baseline and three months 2. Muscle mass is measured by bioelectrical impedance using four-pole mono-frequency equipment (50-kHz, Quantum X, RJL System)at baseline and three months 3. Functionality is evaluated by gait speed (400-m walk test) at baseline and three months

—

Secondary

Measure	Time frame
Phase angle is measured using bioelectrical impedance using four-pole mono-frequency equipment (50-kHz, Quantum X, RJL System) at baseline and three months.	—

Countries

Mexico

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026